Showing 34,561 to 34,590 of 40,456 Clinical Trials
Description Condition(s) Distance Phase Intervention type
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus 2
Other
pharmacologic treatment of the PDA
no pharmacologic treatment of the PDA
Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.
  • Respiratory Insufficiency
  • Clinically Significant Increase in Maximum Expiratory Volume Per Second
2
Drug
Salbutamol
Placebo : physiological serum
Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
  • Carcinoma
  • Liver Neoplasms
  • Carcinoma, Hepatocellular
  • Adult Primary Hepatocellular Carcinoma
  • Advanced Adult Primary Liver Cancer
  • Localized Unresectable Adult Primary Liver Cancer
  • Recurrent Adult Primary Liver Cancer
N/A
Radiation
stereotactic body radiation therapy
A Pilot Study of Perihepatic Phlebotomy During Pancreatic and Hepatic Resections N/A
Other
Perihepatic Phlebotomy
Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode N/A
Device
HiRes™ 90K Advantage implant with HiFocus™ Mid-Scala electrode
Evaluating Behavioral Activation Efficacy in Depressed Spanish-Speaking Latinos
  • Depression
  • Depressive Disorder
N/A
Behavioral
Behavioral Activation for Depression Treatment
Supportive Counseling
Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia 2
Drug
Dasatinib + PegIFN
Improving Outcomes in Neonatal Abstinence Syndrome
  • Neonatal Abstinence Syndrome
  • Substance Withdrawal Syndrome
  • Neonatal Opioid Withdrawal
3
Drug
Neonatal Morphine Solution
Methadone
Phenobarbital
Investigating the Use of Regorafenib (Stivarga®) in Patients With Metastatic Colorectal Cancer (mCRC) After Failure of Standard Therapy
  • Neoplasms
  • Colorectal Neoplasms
  • Colorectal Neoplasm
N/A
Drug
Regorafenib (Stivarga, BAY 73-4506)
Study of Effect of Microfinance on Under 5 Health in Rural India
  • Thinness
  • Malnutrition
  • Underweight
N/A
Other
Early provision of microfinance
Prevention of the Metabolic Syndrome by New Lifestyle Intervention Methods N/A
Behavioral
Weight loss counseling program
CSL311 and Cell Viability in Asthma 2
Drug
CSL 311
Evaluation Of Acceptability And Satisfaction Of Hemophilia Patients Treated With FusENGO 4
Device
Refacto FusENGO
First in Man Study of the DREAMS 2nd Generation Drug Eluting Absorbable Metal Scaffold (BIOSOLVE-II) N/A
Device
Percutaneous Coronary Intervention (DREAMS) stenting
Afatinib (BIBW 2992) in Advanced Non-Small Cell Lung Cancer Patients With EGFR Mutation 3
Drug
Afatinib
Healthy Children, Strong Families: American Indian Communities Preventing Obesity N/A
Behavioral
Healthy Children, Strong Families
Child Safety
Dose-escalation Study to Assess Selumetinib Safety, Tolerability and PK
  • Healthy Volunteers Pharmacokinetic Study
1
Drug
Selumetinib
Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors 2
Drug
imetelstat sodium
Other
laboratory biomarker analysis
pharmacological study
Translational Study for BRAFV600 Serum and Plasma Determination in Patients With BRAFV600 Metastatic Melanoma N/A
Gilenya in Amyotrophic Lateral Sclerosis (ALS) 2
Drug
Gilenya
Safety, Tolerability, PK and PD of BI 655075 and Establishment of BI 655075 Dose(s) Effective to Reverse Prolongation of Blood Coagulation Time by Dabigatran
  • Hemorrhage
1
Drug
BI 655075
Placebo
The Effect of AGE on the Immune System
  • Healthy
N/A
Dietary Supplement
Aged Garlic Extract Supplementation Group
Placebo
Other
Standard for Groups
Effect of Increasing Motor Cortex Inhibition on Task Specific Dystonia N/A
Device
Transcranial Magnetic Stimulation
Pharmacokinetics and Pharmacodynamics of BI 695500 vs. Rituximab as First Line-treatment in Patients With Low Tumor Burden Lymphoma 1
Drug
BI 695500
MabThera
Asenapine for Bipolar Depression 2
Drug
Asenapine
Placebo
Evaluation of Housing Adaptations and Mobility Devices
  • Need for Housing Adaptation Due to Activity Limitations
  • Use of Mobility Devices
N/A
Procedure
New Practice Strategy
Structurally Reorganizing Motor Cortex in Stroke Patients Through Hebbian-type Stimulation N/A
Device
Repetitive Transcranial Magnetic Stimulation (rTMS)
Sham stimulation
Double Endotamponade With Perfluorodecalin and Silicone Oil in Retinal Detachment Surgery. N/A
Procedure
Vitrectomy and tamponade
Biomarkers and Perfusion - Training-Induced Changes After Stroke N/A
Effect of Alirocumab on Lipid Metabolism in Adults With Elevated LDL-Cholesterol 1
Drug
alirocumab SAR236553 (REGN727)
Placebo
Showing 34,561 to 34,590 of 40,456 Clinical Trials